Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study.

Abstract:

BACKGROUND:Increased life expectancy is associated with an increased prevalence of chronic diseases and drug consumption. Changes often occur in the medication regimen after hospitalization. The extent and nature of these changes and the adherence of elderly patients have not yet been fully investigated. OBJECTIVE:To investigate the extent and reasons for modifications to the medication regimens of elderly patients and their adherence to treatment during the first month following hospital discharge. METHODS:This was a prospective cohort study of 198 patients aged>or=65 years in the Acute Geriatric Ward, Beilinson Hospital, Rabin Medical Center, Israel. Clinical, demographic and medication regimen data were recorded for all patients at an interview conducted prior to discharge. After 1 month, the patient, caregiver or general practitioner (GP) were interviewed regarding the extent and reasons for modifications to the medication regimen and adherence to treatment. RESULTS:At 1-month post-discharge, on average, 36.7% of patient medications had been modified compared with the discharge prescription. No modification was found in 16% of patients. During the observation month, 62% of prescribed long-term medications were taken without modification as recommended at discharge and during follow-up, 50% of all changes were characterized by the addition of a drug or an increase in dosage, and 26%, 16% and 8% consisted of cancelling, omission or switching within the same medication type, respectively. Seventy percent of medication regimen changes were based on specialists' recommendations or secondary to a change in the patients' medical state, and 13%, 8%, 3% and 6% were as a result of poor adherence, adverse effects, administrative restrictions and other reasons, respectively. There was no correlation between medication regimen change and age, gender, physical function, cognitive function and length of hospital stay. Patients discharged home experienced less regimen modification than those discharged elsewhere (p=0.02). Patients who visited their GP only once experienced less regimen modification (p=0.03). Regression analysis showed that the only factors affecting medication regimen changes were GP visits and chronic diseases (p<0.01, R2=0.09). The overall mean adherence among 145 home-dwelling patients was 96.7%. Twenty-seven percent and 6% were under- and over-adherent, respectively, to at least one drug; under-adherence was more widespread than over-adherence. No correlation was found between the overall mean adherence and other clinical parameters or regimen change. However, non-adherence to at least one drug was associated with more medication regimen changes (p=0.001), was more common in patients discharged with prescriptions for seven or more drug types per day (p=0.01) and was associated with failing to visit the patient's GP 1 month after discharge (p=0.02). CONCLUSION:The majority of elderly patients experienced modifications in their medication regimen during the first month following hospital discharge. Thirty percent of patients were non-adherent to at least one drug. To improve adherence to a hospital medication regimen, patients should be encouraged to visit their GP and the number of long-term drugs should be reduced.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Mansur N,Weiss A,Hoffman A,Gruenewald T,Beloosesky Y

doi

10.2165/00002512-200825100-00005

subject

Has Abstract

pub_date

2008-01-01 00:00:00

pages

861-70

issue

10

eissn

1170-229X

issn

1179-1969

pii

25105

journal_volume

25

pub_type

杂志文章
  • Meglitinide analogues in the treatment of type 2 diabetes mellitus.

    abstract::Type 2 diabetes mellitus is a complex heterogenous metabolic disorder in which peripheral insulin resistance and impaired insulin release are the main pathogenetic factors. The rapid response of the pancreatic beta-cells to glucose is already markedly disturbed in the early stages of type 2 diabetes mellitus. The cons...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200017050-00007

    authors: Landgraf R

    更新日期:2000-11-01 00:00:00

  • Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): a guide to its use in older adults.

    abstract::Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) (PCV13; Prevenar 13(®); Prevnar 13(®)) is approved in adults aged ≥50 years (focus of review) and in children aged 6 weeks to 5 years for protection against pneumococcal diseases caused by Streptococcus pneumoniae in numerous countries worldwide, incl...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-012-0017-0

    authors: Scott LJ,Sanford M

    更新日期:2012-10-01 00:00:00

  • The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.

    abstract::Rheumatoid arthritis (RA) and osteoarthritis are chronic diseases that result in cartilage degradation and loss of joint function. Currently available drugs are predominantly directed towards the control of pain and/or the inflammation associated with joint synovitis but they do little to reduce joint destruction. In ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118020-00002

    authors: Elliott S,Cawston T

    更新日期:2001-01-01 00:00:00

  • First-line treatment strategies for elderly patients with metastatic colorectal cancer.

    abstract::Colorectal cancer ranks third in incidence in both men and women after lung, breast and prostate cancer. The prevalence of colorectal cancer increases significantly with age, with 40% of patients in Europe being >75 years of age at the time of initial diagnosis. Furthermore, the number of elderly patients with colorec...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200724030-00004

    authors: Meulenbeld HJ,Creemers GJ

    更新日期:2007-01-01 00:00:00

  • Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

    abstract::Lisinopril, the lysine analogue of enalaprilat, is a long-acting angiotensin converting enzyme (ACE) inhibitor which is administered once daily by mouth. The efficacy of lisinopril in reducing blood pressure is well established in younger populations, and many trials now show it to be effective in lowering blood press...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710020-00006

    authors: Langtry HD,Markham A

    更新日期:1997-02-01 00:00:00

  • Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.

    abstract::The incidence of both systolic and diastolic hypertension is increased in elderly patients, therefore antihypertensive drugs are commonly used in this population. In addition to changes in blood pressure, the aging process also causes numerous changes in other physiological parameters, resulting in altered pharmacokin...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101030-00004

    authors: Piepho RW,Fendler KJ

    更新日期:1991-05-01 00:00:00

  • Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.

    abstract:BACKGROUND:Improvement in renal function and decreases in serum uric acid (SUA) have been reported following prolonged high-intensity statin (HMG-CoA reductase inhibitor) therapy. This post hoc analysis of the SAGE trial examined the effect of intensive versus less intensive statin therapy on renal function, safety, an...

    journal_title:Drugs & aging

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s40266-015-0328-z

    authors: Deedwania PC,Stone PH,Fayyad RS,Laskey RE,Wilson DJ

    更新日期:2015-12-01 00:00:00

  • Statin treatment for older adults: the impact of the 2013 ACC/AHA cholesterol guidelines.

    abstract::The 2013 American College of Cardiology (ACC) and American Heart Association (AHA) practice guidelines for the treatment of blood cholesterol significantly changed the paradigm of how providers should prescribe statin therapy, especially for older adults. While the evidence supports statin therapy for older adults wit...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-014-0238-5

    authors: Weinberger Y,Han BH

    更新日期:2015-02-01 00:00:00

  • Age-related endothelial dysfunction : potential implications for pharmacotherapy.

    abstract::Aging per se is associated with abnormalities of the vascular wall linked to both structural and functional changes that can take place at the level of the extracellular matrix, the vascular smooth muscle and the endothelium of blood vessels. Endothelial dysfunction is generally defined as a decrease in the capacity o...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320070-00005

    authors: Matz RL,Andriantsitohaina R

    更新日期:2003-01-01 00:00:00

  • Population Pharmacokinetic/Pharmacodynamic Modeling of O-Desmethyltramadol in Young and Elderly Healthy Volunteers.

    abstract:BACKGROUND:Age-related changes in the concentration-effect relationship of (+)-O-desmethyl-tramadol [(+)-ODM], tramadol's active metabolite, are not documented in the elderly. OBJECTIVE:The objective of this study was to characterize, in elderly and young subjects, the (+)-ODM pharmacokinetic and pharmacodynamic relat...

    journal_title:Drugs & aging

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s40266-019-00681-w

    authors: Robertson SS,Mouksassi MS,Varin F

    更新日期:2019-08-01 00:00:00

  • Association Between Potentially Inappropriate Medications and Hospital Encounters Among Older Adults: A Meta-Analysis.

    abstract:BACKGROUND:Potentially inappropriate medications (PIMs) are defined by the American Geriatric Society as medications that should be avoided in the elderly in general, or in specific situations. However, PIM use remains high among aging populations and may result in increased utilization of healthcare resources. OBJECT...

    journal_title:Drugs & aging

    pub_type: 杂志文章,meta分析

    doi:10.1007/s40266-020-00770-1

    authors: Weeda ER,AlDoughaim M,Criddle S

    更新日期:2020-07-01 00:00:00

  • Induction immunosuppression in kidney transplant recipients older than 60 years of age : safety and efficacy of ATGAM, OKT3 and Simulect.

    abstract:BACKGROUND:The choice of induction immunosuppression for kidney transplantation in elderly recipients is dictated by the consideration of the risk of infection as well as efficacy in the prevention of acute rejection, thus allowing a reduction in subsequent maintenance immunosuppression and its attendant long-term adve...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200421110-00005

    authors: Heifets M,Saeed MI,Parikh MH,Sierka D,Kumar MS

    更新日期:2004-01-01 00:00:00

  • Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study.

    abstract:BACKGROUND:Inappropriate medications are often used in older adults despite their unfavourable risk-to-benefit profile. Although many of the medications in the American Geriatrics Society (AGS) Beers list are potentially inappropriate because of their anticholinergic properties, little is known regarding the nature and...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-015-0257-x

    authors: Kachru N,Carnahan RM,Johnson ML,Aparasu RR

    更新日期:2015-05-01 00:00:00

  • Does lithium prevent Alzheimer's disease?

    abstract::Lithium salts have a well-established role in the treatment of major affective disorders. More recently, experimental and clinical studies have provided evidence that lithium may also exert neuroprotective effects. In animal and cell culture models, lithium has been shown to increase neuronal viability through a combi...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11599180-000000000-00000

    authors: Forlenza OV,de Paula VJ,Machado-Vieira R,Diniz BS,Gattaz WF

    更新日期:2012-05-01 00:00:00

  • Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

    abstract::The focus of this review is hormone replacement therapy (HRT) with continuous oral 17 beta-estradiol (herein referred to as estradiol) 2 mg/day plus sequential oral dydrogesterone 10 or 20 mg/day for 14 days of each 28-day cycle. According to data from nonblind trials, this regimen relieves climacteric symptoms, prese...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199711040-00006

    authors: Foster RH,Balfour JA

    更新日期:1997-10-01 00:00:00

  • Reduction of inappropriate medications among older nursing-home residents: a nurse-led, pre/post-design, intervention study.

    abstract:BACKGROUND:Medication-related problems are common in the growing population of older adults and inappropriate prescribing is a preventable risk factor. Explicit criteria such as the Beers criteria provide a valid instrument for describing the rate of inappropriate medication (IM) prescriptions among older adults. OBJE...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11584770-000000000-00000

    authors: Blozik E,Born AM,Stuck AE,Benninger U,Gillmann G,Clough-Gorr KM

    更新日期:2010-12-01 00:00:00

  • Interventions to Improve Medicines Management for People with Dementia: A Systematic Review.

    abstract:BACKGROUND:The importance of optimising medicines management for people with dementia has been emphasised through research and policy. However, evidence is currently lacking regarding how to achieve this in this patient population. OBJECTIVE:The aim was to assess the effectiveness of medicines management interventions...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0505-3

    authors: McGrattan M,Ryan C,Barry HE,Hughes CM

    更新日期:2017-12-01 00:00:00

  • Clinical, demographic and functional characteristics associated with pharmacotherapy for heart failure in older home care clients: a retrospective, population-level, cross-sectional study.

    abstract:BACKGROUND:Use of combination pharmacotherapy, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II type 1 receptor antagonists (angiotensin receptor blockers) and β-adrenoceptor antagonists (β-blockers) in the management of heart failure (HF) can reduce mortality, prevent functional decline and red...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11592420-000000000-00000

    authors: Foebel AD,Heckman GA,Hirdes JP,Tyas SL,Tjam EY,McKelvie RS,Maxwell CJ

    更新日期:2011-07-01 00:00:00

  • Quinolone disposition in the elderly. Practical implications.

    abstract::The fluoroquinolones are antibiotics frequently used in infections that affect elderly individuals. The physiological aging process can profoundly affect the pharmacokinetics of drugs, necessitating adjustment of dosage regimens in the elderly. Changes in pharmacokinetics with age are mainly due to the progressive det...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101040-00004

    authors: Nilsson-Ehle I,Ljungberg B

    更新日期:1991-07-01 00:00:00

  • Therapeutic efficacy of bevacizumab for age-related macular degeneration: what are the implications of CATT for routine management?

    abstract::CATT (Comparison of Age-related macular degeneration [AMD] Treatment Trials) examined the efficacy of ranibizumab and bevacizumab for the treatment of neovascular AMD. This prospective, randomized, but unblinded trial revealed a significant improvement in vision with both treatments in terms of visual acuity; importan...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11594720-000000000-00000

    authors: Ziemssen F,Sobolewska B

    更新日期:2011-11-01 00:00:00

  • A comparative review of apomorphine formulations for erectile dysfunction : recommendations for use in the elderly.

    abstract::Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of men worldwide. First-line oral therapy for ED includes the use of phosphodiesterase type 5 inhibitors (sildenafil, tadalafil and vardenafil) and sublingual apomorphine. Apomorphine is a dopamine D(1) and D(2) receptor a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200623040-00004

    authors: Briganti A,Chun FK,Salonia A,Zanni G,Dehò F,Barbieri L,Karakiewicz PI,Rigatti P,Montorsi F

    更新日期:2006-01-01 00:00:00

  • Benzodiazepines and injurious falls in community dwelling elders.

    abstract:BACKGROUND:Benzodiazepines are frequently used medications in the elderly, in whom they are associated with an increased risk of falling, with sometimes dire consequences. OBJECTIVE:To estimate the impact of benzodiazepine-associated injurious falls in a population of elderly persons. METHOD:A nested case-control stu...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200825010-00007

    authors: Pariente A,Dartigues JF,Benichou J,Letenneur L,Moore N,Fourrier-Réglat A

    更新日期:2008-01-01 00:00:00

  • Intermittent claudication in older patients. Practical treatment guidelines.

    abstract::The prevalence of intermittent claudication (IC) increases with age; when questioned, older patients consider increased difficulty in walking to be a normal consequence of aging. Although the prognosis for the involved limb with IC is relatively good, IC is an important clinical predictor of increased cardiovascular m...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199914040-00002

    authors: Boccalon H

    更新日期:1999-04-01 00:00:00

  • Bacterial skin infections in the elderly: diagnosis and treatment.

    abstract::Skin and soft tissue infections are quite common in elderly people. A number of special conditions and circumstances need to be considered in the diagnosis and therapy. It is important to try to establish the causative organism, exclude other cutaneous disorders and identify precipitating factors. Treatment modalities...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200219050-00002

    authors: Laube S,Farrell AM

    更新日期:2002-01-01 00:00:00

  • The Role of Deprescribing in Older Adults with Chronic Kidney Disease.

    abstract::Older adults with chronic kidney disease (CKD) often experience polypharmacy, a recognized predictor of prescribing problems including inappropriately dosed medications, drug-drug and drug-disease interactions, morbidity and mortality. Polypharmacy is also associated with nonadherence, which leads to recurrent hospita...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-018-0593-8

    authors: Triantafylidis LK,Hawley CE,Perry LP,Paik JM

    更新日期:2018-11-01 00:00:00

  • A brief history of pneumococcal vaccines.

    abstract::Attempts to control pneumococcal infection by vaccination, undertaken initially in 1911, have gone through 3 phases during the subsequent 8 decades. Initially, vaccines of killed pneumococcal cells prepared in a variety of ways were used in epidemic settings with inconclusive results, although administered to approxim...

    journal_title:Drugs & aging

    pub_type: 历史文章,杂志文章

    doi:10.2165/00002512-199915001-00001

    authors: Austrian R

    更新日期:1999-01-01 00:00:00

  • High prevalence of medication non-adherence in a sample of community-dwelling older adults with adult protective services-validated self-neglect.

    abstract:BACKGROUND:Medication non-adherence can exacerbate disease severity, leading to impairments that interfere with self-care activities in older adults, and, ultimately, death. Elder self-neglect is the most common report to Adult Protective Services (APS) across the USA and is a significant risk factor for early mortalit...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-012-0007-2

    authors: Turner A,Hochschild A,Burnett J,Zulfiqar A,Dyer CB

    更新日期:2012-09-01 00:00:00

  • Treatment of systemic fungal infections in older patients: achieving optimal outcomes.

    abstract::Systemic fungal infections are an increasing problem in older adults. For several of the endemic mycoses, this increase is the result of increased travel and leisure activities in areas endemic for these fungi. Immunosuppressive agents, care in an intensive care unit, and invasive devices all contribute to infection w...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118050-00002

    authors: Kauffman CA,Hedderwick SA

    更新日期:2001-01-01 00:00:00

  • The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.

    abstract::The median age for breast cancer diagnosis is 62 years, but a disproportionate number of patients are over the age of 75 years and the majority of those have hormone receptor-positive, human epidermal growth factor receptor-2 (HER2)-negative cancers. This review provides a logical algorithm to guide providers through ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-020-00748-z

    authors: Sammons S,Sedrak MS,Kimmick GG

    更新日期:2020-05-01 00:00:00

  • Update on oral cyanocobalamin (vitamin B12) treatment in elderly patients.

    abstract::The objective of this review is to evaluate the usefulness of oral cobalamin (vitamin B12) treatment in elderly patients. PubMed was systematically searched for English and French articles published from January 1990 to January 2007. Prospective randomized studies (n=3), a systematic review by the Cochrane group (n=1)...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/0002512-200825110-00003

    authors: Andrès E,Vogel T,Federici L,Zimmer J,Kaltenbach G

    更新日期:2008-01-01 00:00:00